ScienceAlert on MSN2h
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...
California will spend $2.5 billion to help the Los Angeles area recover from wildfires
The California state Legislature has approved a more than $2.5 billion package to help the Los Angeles area recover from its recent deadly wildfires.
Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.